Trulicity is a brand of dulaglutide, a weekly GLP-1 agent PlexusDx does not carry. This guide explains what "compounded Trulicity" would mean under 503A rules, how compounded preparations differ from brand products, and where genetic pathway insight belongs in the conversation you have with a provider.

Zepbound and Trulicity are both Eli Lilly injections, yet they were built for different jobs: tirzepatide for chronic weight management, dulaglutide for type 2 diabetes. This independent review compares receptor mechanism, FDA labels, trial evidence, tolerability, and cost, then looks at the FTO genetics that sit upstream of either choice.

What does Trulicity actually cost? This independent review walks the published list price down through insurance, prior authorization, manufacturer savings cards, and compounding pathways to realistic out-of-pocket scenarios, plus the genetic context PlexusDx applies before any GLP-1 decision, as of April 2026.

Trulicity (dulaglutide) coupons come in two forms: Eli Lilly's manufacturer savings card and third-party pharmacy discounts. This independent review explains how each works, the published list price, why insurance status matters, and how compounded routes fit — reported as published, as of April 2026.

Trulicity is a long-acting GLP-1 receptor agonist that many people search in a weight-loss context. This guide walks through its receptor-level mechanism, the AWARD and REWIND trial evidence, its FDA-approved indications, the boxed warning, and the genetic variants that sit upstream of every GLP-1 conversation.

Trulicity (dulaglutide, Eli Lilly) is a GLP-1 receptor agonist with a well-characterized safety profile. This article covers common side effects, serious warnings, the boxed-warning context, and when to call a provider — plus the genetic variables that shape baseline GLP-1 biology.